125 related articles for article (PubMed ID: 28710239)
1. Anaphylaxis secondary to
Vella C; Sammut P
BMJ Case Rep; 2017 Jul; 2017():. PubMed ID: 28710239
[TBL] [Abstract][Full Text] [Related]
2. Possible relationship between systemic side effects and sensitization to rPar j 2 in allergic patients submitted to an ultra-rush (20 min) sublingual immunotherapy and selected by component resolved diagnosis.
Rossi RE; Monasterolo G; Coco G; Operti D
Int Arch Allergy Immunol; 2005 Oct; 138(2):105-10. PubMed ID: 16174987
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis of Parietaria judaica pollen allergy using natural and recombinant Par j 1 and Par j 2 allergens.
González-Rioja R; Ferrer A; Arilla MC; Ibarrola I; Viguera AR; Andreu C; Martínez A; Asturias JA
Clin Exp Allergy; 2007 Feb; 37(2):243-50. PubMed ID: 17250697
[TBL] [Abstract][Full Text] [Related]
4. Cross-reactivity between
Cancelliere N; Iglesias I; Ayuga Á; Enrique Miranda E
Biomed Rep; 2020 Jun; 12(6):326-332. PubMed ID: 32346476
[No Abstract] [Full Text] [Related]
5. Parietaria pollinosis in an Atlantic area: clinical and palynological data.
Vidal C; Dopazo A; Aira MJ
J Investig Allergol Clin Immunol; 2001; 11(2):107-11. PubMed ID: 11642568
[TBL] [Abstract][Full Text] [Related]
6. A sensitive monoclonal antibody-based enzyme-linked immunosorbent assay to quantify Parietaria judaica major allergens, Par j 1 and Par j 2.
Arilla MC; González-Rioja R; Ibarrola I; Mir A; Monteseirín J; Conde J; Martínez A; Asturias JA
Clin Exp Allergy; 2006 Jan; 36(1):87-93. PubMed ID: 16393270
[TBL] [Abstract][Full Text] [Related]
7. Proteomic analysis of Parietaria judaica pollen and allergen profiling by an immunoproteomic approach.
Barranca M; Fontana S; Taverna S; Duro G; Zanella-Cleon I; Becchi M; De Leo G; Alessandro R
Biotechnol Lett; 2010 Apr; 32(4):565-70. PubMed ID: 19953298
[TBL] [Abstract][Full Text] [Related]
8. The allergens of Parietaria.
Colombo P; Bonura A; Costa M; Izzo V; Passantino R; Locorotondo G; Amoroso S; Geraci D
Int Arch Allergy Immunol; 2003 Mar; 130(3):173-9. PubMed ID: 12660421
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy with a mass unit Parietaria judaica extract: a tolerance study with evidence of immunological changes to the major allergen Par j 1.
García Villalmanzo I; Hernández MD; Campos A; Giner AM; Polo F; Cortés C; Basomba A
J Investig Allergol Clin Immunol; 1999; 9(5):321-9. PubMed ID: 10582201
[TBL] [Abstract][Full Text] [Related]
10. Genetically engineered hybrid proteins from Parietaria judaica pollen for allergen-specific immunotherapy.
González-Rioja R; Ibarrola I; Arilla MC; Ferrer A; Mir A; Andreu C; Martínez A; Asturias JA
J Allergy Clin Immunol; 2007 Sep; 120(3):602-9. PubMed ID: 17561242
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of cross-reactivity between Holoptelea integrifolia and Parietaria judaica.
Sharma S; Panzani RC; Gaur SN; Ariano R; Singh AB
Int Arch Allergy Immunol; 2005 Feb; 136(2):103-12. PubMed ID: 15650307
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of oral immunotherapy in respiratory allergy to Parietaria judaica pollen. A double-blind study.
Ariano R; Panzani RC; Augeri G
J Investig Allergol Clin Immunol; 1998; 8(3):155-60. PubMed ID: 9684188
[TBL] [Abstract][Full Text] [Related]
13. Cross-reactivity between Parietaria species using the major rParj1 and rParj2 allergens.
Bonura A; Artale A; Marino M; Amoroso S; Marcucci F; Geraci D; Colombo P
Allergy Asthma Proc; 2006; 27(5):378-82. PubMed ID: 17063667
[TBL] [Abstract][Full Text] [Related]
14. Antigenic activity of nonpollen parts (leaves and stems) of allergenic plants (Parietaria judaica and Dactylis glomerata).
D'Amato G; De Palma R; Verga A; Martucci P; Liccardi G; Lobefalo G
Ann Allergy; 1991 Oct; 67(4):421-4. PubMed ID: 1952298
[TBL] [Abstract][Full Text] [Related]
15. PCR-based cloning and immunological characterization of Parietaria judaica pollen profilin.
Asturias JA; Ibarrola I; Eseverri JL; Arilla MC; González-Rioja R; Martínez A
J Investig Allergol Clin Immunol; 2004; 14(1):43-8. PubMed ID: 15160441
[TBL] [Abstract][Full Text] [Related]
16. Parietaria judaica and dermo-respiratory allergy in Barcelona: a study of 250 cases.
Valero Santiago A; Malet i Casajuana A; García Calderón PA
Allergol Immunopathol (Madr); 1988; 16(4):209-14. PubMed ID: 2465679
[TBL] [Abstract][Full Text] [Related]
17. Sensitivity to Parietaria officinalis and Parietaria judaica pollen allergens in a Spanish population.
Dreborg S; Basomba A; Einarsson R
Allergol Immunopathol (Madr); 1986; 14(6):499-508. PubMed ID: 3825837
[TBL] [Abstract][Full Text] [Related]
18. Parietaria judaica flowering phenology, pollen production, viability and atmospheric circulation, and expansive ability in the urban environment: impacts of environmental factors.
Fotiou C; Damialis A; Krigas N; Halley JM; Vokou D
Int J Biometeorol; 2011 Jan; 55(1):35-50. PubMed ID: 20411278
[TBL] [Abstract][Full Text] [Related]
19. Detection and release of allergenic proteins in Parietaria judaica pollen grains.
Vega-Maray AM; Fernández-González D; Valencia-Barrera R; Suárez-Cervera M
Protoplasma; 2006 Aug; 228(1-3):115-20. PubMed ID: 16937063
[TBL] [Abstract][Full Text] [Related]
20. High-dose sublingual immunotherapy in patients with uncontrolled allergic rhinitis sensitized to pollen: a real-life clinical study.
Irani C; Saleh RA; Jammal M; Haddad F
Int Forum Allergy Rhinol; 2014 Oct; 4(10):802-7. PubMed ID: 25224283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
